Carcinoma News and Research

RSS
Carcinoma is cancer that begins in the skin or in tissues that line or cover internal organs.
Maintenance therapy with olaparib improves progression-free survival in advanced ovarian cancer patients

Maintenance therapy with olaparib improves progression-free survival in advanced ovarian cancer patients

Study shows potential of avelumab plus axitinib as new treatment option for patients with advanced RCC

Study shows potential of avelumab plus axitinib as new treatment option for patients with advanced RCC

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Exelixis presents CABOSUN and METEOR trial results in patients with advanced renal cell carcinoma

Exelixis presents CABOSUN and METEOR trial results in patients with advanced renal cell carcinoma

X4 Pharmaceuticals announces clinical data of X4P-001-IO and Opdivo in patients with clear cell renal cell carcinoma

X4 Pharmaceuticals announces clinical data of X4P-001-IO and Opdivo in patients with clear cell renal cell carcinoma

Breast Cancer as a Dynamic Disease

Breast Cancer as a Dynamic Disease

LJI and UC San Diego awarded $ 4.5 million as part of NCI's Cancer Moonshot initiative

LJI and UC San Diego awarded $ 4.5 million as part of NCI's Cancer Moonshot initiative

Sleeping Beauty technique helps identify genes responsible for NAFLD-associated liver cancer

Sleeping Beauty technique helps identify genes responsible for NAFLD-associated liver cancer

New pragmatic study launched to understand the effectiveness of new type 2 diabetes drug

New pragmatic study launched to understand the effectiveness of new type 2 diabetes drug

Researchers identify basic relationships of cell cycle and cellular senescence in the placenta

Researchers identify basic relationships of cell cycle and cellular senescence in the placenta

Scientists shed light on roles of transcription factors, TP63 and SOX2, in squamous cell carcinoma

Scientists shed light on roles of transcription factors, TP63 and SOX2, in squamous cell carcinoma

Study identifies molecular switch that controls fate of milk-producing breast cells

Study identifies molecular switch that controls fate of milk-producing breast cells

Study identifies tumor cell population responsible for resistance to therapy and cancer relapse

Study identifies tumor cell population responsible for resistance to therapy and cancer relapse

New blood test may detect early-stage lung cancer when surgical intervention is not possible

New blood test may detect early-stage lung cancer when surgical intervention is not possible

Alnylam submits CTA application to MHRA to initiate Phase 1/2 study of ALN-AAT02

Alnylam submits CTA application to MHRA to initiate Phase 1/2 study of ALN-AAT02

Bacterial therapy shows early clinical efficacy in patients with treatment-refractory solid tumors

Bacterial therapy shows early clinical efficacy in patients with treatment-refractory solid tumors

FDA approves first intravenous treatment for metastatic cutaneous squamous cell carcinoma

FDA approves first intravenous treatment for metastatic cutaneous squamous cell carcinoma

Researchers analyze response to combination immunotherapy for patients with rare skin cancer

Researchers analyze response to combination immunotherapy for patients with rare skin cancer

New nanoplatform technology may reverse drug-resistance in renal cell carcinoma

New nanoplatform technology may reverse drug-resistance in renal cell carcinoma

China NMPA approves LENVIMA for treatment of unresectable hepatocellular carcinoma

China NMPA approves LENVIMA for treatment of unresectable hepatocellular carcinoma

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.